KDNY — Chinook Therapeutics Share News
0.000.00%
- $2.90bn
- $2.60bn
- $6.13m
Chinook Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Chinook Therapeutics Inc expected to post a loss of 81 cents a share - Earnings Preview
Brief: Chinook Therapeutics Announces First Patient Enrolled In Phase 3 Of Zigakibart
Brief: Muddy Waters- Remains Short On Chinook Therapeutics Inc
Brief: Chinook Therapeutics To Present Updated Data From Zigakibart Phase 1/2 Trial
U.S. STOCKS ON THE MOVE-Precision Optics, Tesla, airline stocks
Chinook Therapeutics surges on $3.5 bln buyout deal with Novartis
Chinook Therapeutics surges on $3.5 bln buyout deal with Novartis
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Catalent, Marker Therapeutics, Genelux
U.S. STOCKS ON THE MOVE-Chinook Therapeutics, Nasdaq, Carnival Corp
Refinitiv Newscasts - U.S. Morning Call: Dollar slips as traders predict Fed rate pause
Brief: Chinook Therapeutics Inc Says Co Will Be Obligated To Pay Termination Fee Of $112 Million To Novartis
Deals of the day-Mergers and acquisitions
Chinook Therapeutics surges on $3.5 bln buyout deal with Novartis
Novartis to buy Chinook for up to $3.5 bln in boost to late-stage pipeline (updated)
Novartis to acquire US-based Chinook for $3.2 bln upfront
Brief: Chinook Therapeutics Enters Into Agreement To Be Acquired By Novartis AG
Brief: Muddy Waters Says Remains Short Chinook Therapeutics Inc